✦ LIBER ✦

PMS35 COST-EFFECTIVENESS OF BIOLOGIC THERAPEUTIC SEQUENCES FOR RHEUMATOID ARTHRITIS IN THE UK

✍ Scribed by Emery, P; Taylor, P; Isaacs, JD; Drost, P; Dupont, D; Beresniak, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS80 Biologic Therapies for Rheumatoid

✍ M. Lebmeier; C. Righetti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS39 SEQUENTIAL COST-EFFECTIVENESS MODE

✍ Beresniak, A; Hamuryudan, V; Inane, M; Pay, S; Yazici, H; Ozdedeli, S; Drost, P; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PMS50 Cost-Effectiveness of Biologic Age

✍ C. Valle-Mercado; M.F. Cubides; M. Parra-Torrado; D. Rosselli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS11 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ SF Lou; DY Chen; TT Cheng; CM Huang; HY Lin; CC Su; WC Tsai; JC Tseng; CC Wei; L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PMS13 COST EFFECTIVENESS OF BIOLOGICS FO

✍ B Pham; K McMartin; M Bornstein; M Machado; C Bombardier; MD Krahn; L Levin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMS30 Cost-Effectiveness of Tocilizumab

✍ A. Diamantopoulos; S. Andrade; A. Bernardo; J. Branco; L. Inês; J.A. Pereira da 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB